Morning Market Gainers

shares surged 40.99% to $4.54 after the company announced an exclusive licensing agreement with NeuPharma to develop and commercialize novel covalent 3rd generation EGFR inhibitors.

shares jumped 29.63% to $12.12 on announcement of positive global regulatory updates from the EMA and the FDA meetings for Fabry monotherapy.

shares gained 16.20% to $8.75. Health Insurance Innovations reported Q4 earnings $0.12 per share.

shares surged 13.89% to $19.07 after the company reported stronger-than-expected earnings for its fourth quarter.

rose 11.89% to $47.25. Nevro reported a Q4 loss of $0.59 per share on revenue of $9.7 million.

shares surged 9.76% to $14.73 after the company reported better-than-expected earnings for the fiscal fourth quarter.

shares jumped 7.15% to $113.28 after the company announced the pricing of 1.75 million share offering at $100.00 per share.

shares rose 4.83% to $25.39 after the company reported stronger-than-expected results for the fourth quarter.

shares rose 4.05% to $4.11 after the company reported financial results for the fourth quarter. Non-GAAP net income attributable to NQ Mobile came in at $3.2 million, or $0.03 per ADS in the latest quarter.

shares gained 1.19% to $50.31 after the company reported stronger-than-expected earnings for the first quarter.